VenoStent is a startup based in the United States, most recent round Series A, 3 tracked investors.
VenoStent is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
VenoStent develops a bioabsorbable, flexible vascular wrap called SelfWrap designed to reduce dialysis access site failures and improve outcomes for patients undergoing vascular surgery, particularly for renal dialysis access.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.